• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Engineered Blood Vessels Coming down the Pipe

  • in AHA 2005 · Cardiovascular
  • — 17 Nov, 2005
Engineered Blood Vessels Coming down the Pipe
AudioMedica News
Engineered Blood Vessels Coming down the Pipe
Engineered Blood Vessels Coming down the Pipe
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-33"/>
Todd McAllister
Todd McAllister

Blood vessels made through tissue engineering are being trialled in humans and may provide a future source of grafts from coronary applications. That is the latest from a California-based company, Cytograft, who presented details of their methods and current human trial at the AHA meeting. Todd McAllister told Audio Medica how it all works.
[audio:https://www.audiomedica.com/podcasting/aha2005/Todd_McAllister.mp3]

Click here for all the interviews from AHA 2005

You may also like...

  • Heart Attacks Drop After Smoking Ban in Ireland Heart Attacks Drop After Smoking Ban in Ireland 5 Sep, 2007
  • Audio Journal of Cardiovascular Medicine 11.1, January 2005 Audio Journal of Cardiovascular Medicine 11.1, January 2005 8 Jan, 2006
  • Simon Thom Polypill—even better for coronary prevention among those at high risk 12 Nov, 2012
  • Hypertension: Pressure Different at the Centre Hypertension: Pressure Different at the Centre 16 Nov, 2005

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Drug-eluting Stents: No Benefit in Vein Grafts
  • Next story Warfarin Trumps Platelet Agents in Atrial Fibrilation
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Childhood Obesity—Whose Business Is It?
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Superior Survival in Conservatively Treated Male…
  • Home
  • Cardiovascular
  • AHA 2005
  • Engineered Blood Vessels Coming down the Pipe

© COPYRIGHT 2020 AUDIOMEDICA.COM.